Related Experiment Video
Updated: Jul 16, 2026

Rapid Identification of Gram Negative Bacteria from Blood Culture Broth Using MALDI-TOF Mass Spectrometry
Published on: May 28, 2014
Development of a MALDI-TOF MS model for differentiating haemorrhagic septicaemia-causing strains of Pasteurella
Kelli Maddock1, Brianna L S Stenger2, Jill C Roberts3
1Veterinary Diagnostic Laboratory, North Dakota State University, Fargo, ND, USA; College of Public Health, University of South Florida, Tampa, FL, USA.
Abstract:
Pasteurella multocida capsular types A, D, and F cause disease in many animal hosts, including bovine respiratory disease in cattle, which is one of the most globally significant animal diseases. Additionally, P. multocida capsular types B and E cause haemorrhagic septicaemia, a devastating disease primarily of cattle, water buffalo, and bison that develops rapidly with high mortality. Haemorrhagic septicaemia mostly occurs in developing countries and has potential to emerge elsewhere in the world. The diagnosis of haemorrhagic septicaemia currently requires recognition of compatible gross or histologic lesions and serotyping or molecular characterization of strains. In this study, we performed genomic characterization of 84 P. multocida strains, which were then used to develop and validate a matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) biomarker-based method for differentiating non-haemorrhagic septicaemia strains of P. multocida from haemorrhagic septicaemia-causing strains. Haemorrhagic septicaemia strain types B:2,5, E:2,5, and B:3,4 were used to maximize diversity. Three automated classification models were generated and then used to develop an assisted model, which utilized two peaks (6419 and 7729 m/z) to accurately differentiate non-haemorrhagic septicaemia-causing strains from haemorrhagic septicaemia-causing strains of P. multocida. The assisted model performed with 98.2 % accuracy for non-haemorrhagic septicaemia strains, 100 % accuracy for classic B:2,5 and E:2,5 strains, and 84.4 % accuracy for combined haemorrhagic septicaemia-causing strains (B:2,5, E:2,5, and B:3,4) with an overall accuracy of 96.9 %. Our results suggest that MALDI-TOF MS may be used to routinely screen P. multocida isolated from diagnostic cases for initial identification of haemorrhagic septicaemia-causing strains, and to determine whether additional characterizations are warranted.
Insights
A new matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) method accurately distinguishes haemorrhagic septicaemia strains of Pasteurella multocida. This rapid diagnostic tool can aid in identifying severe P. multocida infections in animals.
Area of Science:
- Veterinary Microbiology
- Animal Infectious Diseases
- Mass Spectrometry Applications
Background:
- Pasteurella multocida causes significant animal diseases, including bovine respiratory disease and devastating haemorrhagic septicaemia.
- Current diagnosis of haemorrhagic septicaemia relies on lesion recognition and laborious serotyping or molecular methods.
- Haemorrhagic septicaemia, caused by P. multocida capsular types B and E, poses a high mortality risk and has pandemic potential.
Purpose of the Study:
- To develop and validate a rapid diagnostic method for differentiating haemorrhagic septicaemia-causing P. multocida strains from other types.
- To utilize genomic data for creating a biomarker-based assay for P. multocida strain identification.
- To improve the timely diagnosis of haemorrhagic septicaemia for effective disease management.
Main Methods:
- Genomic characterization of 84 P. multocida strains, including haemorrhagic septicaemia types (B:2,5, E:2,5, B:3,4).
- Development of a matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) method using specific protein peaks (6419 and 7729 m/z).
- Validation of three automated classification models and an assisted model for strain differentiation.
Main Results:
- The assisted MALDI-TOF MS model achieved high accuracy: 98.2% for non-haemorrhagic septicaemia strains and 100% for classic haemorrhagic septicaemia strains (B:2,5 and E:2,5).
- Overall accuracy for differentiating haemorrhagic septicaemia strains (B:2,5, E:2,5, B:3,4) was 96.9%.
- The method demonstrated robust performance in distinguishing between disease-causing P. multocida types.
Conclusions:
- MALDI-TOF MS offers a rapid and accurate approach for the initial screening of P. multocida isolates.
- This method can facilitate the early identification of haemorrhagic septicaemia-causing strains in diagnostic settings.
- Routine implementation of this MALDI-TOF MS assay can guide further characterization and disease control strategies.
Related Concept Videos
MALDI-TOF Mass Spectrometry
Rapid Identification of Pathogens

